John E. Anderson, MD - Realizing Your Patient ’s Potential: Embracing the Guidelines to Appropriately Individualize Care for Patients With Type 2 Diabetes
Go online to PeerView.com/UQE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in internal medicine offers insight on providing patient-centered diabetes care and developing individualized treatment plans for patients with type 2 diabetes mellitus (T2DM). Upon completion of this activity, participants should be better able to: Recognize the primary goals of treatment and key components involved in providing effective patient-centered care to individuals with T2DM, Apply recommendations offered in current evidence-based guidelines to appropria...
Source: PeerView CME/CE Audio Podcast - Endocrinology - May 6, 2019 Category: Endocrinology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
JAMA Internal Medicine : Allocation of Inpatient Time Among First-Year Internal Medicine Residents
Interview with Krisda Hirschman Chaiyachati, MD, MPH, MSHP, author of Assessment of Inpatient Time Allocation Among First-Year Internal Medicine Residents Using Time-Motion Observations, and Christopher Moriates, MD, author of A Modern Snapshot of the Daily Work of Medical Interns—The Burden of Indirect Patient Care (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - April 15, 2019 Category: General Medicine Source Type: podcasts
JAMA Internal Medicine : A Clinical Overview of Off-label Use of Gabapentinoid Drugs
Interview with Christopher W. Goodman, MD, author of A Clinical Overview of Off-label Use of Gabapentinoid Drugs (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - March 25, 2019 Category: General Medicine Source Type: podcasts
Anas Younes, MD - Progress in Developing Novel Treatment Options for PTCL: Expert Views on Integrating Innovative Therapeutics Into Care
Progress in Developing Novel Treatment Options for PTCL: Expert Views on Integrating Innovative Therapeutics Into Care (Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine)
Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine - February 15, 2019 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Robert Anders, MD, PhD - The Central Role of Biomarker Testing in Piecing Together the Immuno-Oncology Puzzle: Essential Guidance for Pathologists to Maximize the Potential of Cancer Immunotherapies
The Central Role of Biomarker Testing in Piecing Together the Immuno-Oncology Puzzle: Essential Guidance for Pathologists to Maximize the Potential of Cancer Immunotherapies (Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine)
Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine - February 13, 2019 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
JAMA Internal Medicine : Changes in Functional Status in the Year After Aortic Valve Replacement
Interview with Dae Hyun Kim, author of Evaluation of Changes in Functional Status in the Year After Aortic Valve Replacement, and Emily Finlayson, MD, MS, author of Invasive Procedures to Improve Function in Frail Older Adults: Do Outcomes Justify the Intervention? (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - February 4, 2019 Category: General Medicine Source Type: podcasts
Michael B. Atkins, MD - Incorporating Cancer Immunotherapies Into the Oncology Treatment Arsenal in Managed Care Settings: Navigating the Complexities of Value Assessment & Cost Optimization in the Era of Immuno-Oncology
Incorporating Cancer Immunotherapies Into the Oncology Treatment Arsenal in Managed Care Settings: Navigating the Complexities of Value Assessment & Cost Optimization in the Era of Immuno-Oncology (Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine)
Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine - January 18, 2019 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Results Of The AUGMENT Study In Relapsed/Refractory Indolent NHL
Julie Vose, MD, Professor, Internal Medicine Division of Oncology & Hematology University of Nebraska Medical Center, discusses Results Of The AUGMENT Study In Relapsed/Refractory Indolent NHL. At The...
Author: obr
Added: 01/15/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 15, 2019 Category: Cancer & Oncology Source Type: podcasts
Improvements Made In The Delivery Of CAR-T Therapies
Julie Vose, MD, Professor, Internal Medicine Division of Oncology & Hematology University of Nebraska Medical Center, Discusses Improvements Made In The Delivery Of CAR-T Therapies. At The 60th ASH An...
Author: obr
Added: 01/15/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 15, 2019 Category: Cancer & Oncology Source Type: podcasts
The Current Standard Of Care For The Frontline Treatment Of PTCL
Lorenz Trumper, MD, Professor of Internal Medicine and Chairman of the Department of Hematology and Oncology, Georg August University of Gttingen, discusses The Current Standard Of Care For The Front...
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
What Differeniates Brentuximab Vedotin From Other Treatment Options
Lorenz Trumper, MD, Professor of Internal Medicine and Chairman of the Department of Hematology and Oncology, Georg August University of Gttingen, discusses What Differeniates Brentuximab Vedotin Fro...
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
Management Of Common Toxicities With CAR-T Therapies
Julie Vose, MD Professor, Internal Medicine Division of Oncology & Hematology University of Nebraska Medical Center, discusses Management Of Common Toxicities With CAR-T Therapies. At The 60th ASH Ann...
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
Does Polatuzumab Improve Outcomes In DLBCL Patients
Julie Vose, MD Professor Internal Medicine Division of Oncology & Hematology University of Nebraska Medical Center, discusses Does Polatuzumab Improve Outcomes In DLBCL Patients. At The 60th ASH Annua...
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
JAMA Internal Medicine : Analysis of Proposed Medicare Reforms on Prescription Drug Total Spending and Patient Cost-Sharing
Interview with Aaron Kesselheim, author of Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs, and Francis J. Crosson, M.D., author of Managing the Cost of Medicare Part B Drugs: Implications for the Program and Beneficiaries (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - January 14, 2019 Category: General Medicine Source Type: podcasts
Differences Between B-Cell And T-Cell Lymphomas
Lorenz Trumper, MD Professor of Internal Medicine and Chairman of the Department of Hematology and Oncology, Georg August University of Gttingen discusses Differences Between B-Cell And T-Cell Lympho...
Author: obr
Added: 01/13/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
